Klingman & Associates’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$662K Buy
1,665
+457
+38% +$200K 0.03% 173
2026
Q1
$557K Sell
1,208
-14
-1% -$7.08K 0.03% 183
2025
Q4
$692K Buy
1,222
+71
+6% +$37.8K 0.03% 157
2025
Q3
$515K Buy
1,151
+58
+5% +$27.8K 0.03% 186
2025
Q2
$594K Buy
1,093
+254
+30% +$133K 0.03% 154
2025
Q1
$416K Buy
839
+59
+8% +$32.6K 0.03% 179
2024
Q4
$407K Buy
780
+55
+8% +$28.6K 0.03% 173
2024
Q3
$356K Buy
725
+44
+6% +$20.5K 0.02% 199
2024
Q2
$303K Buy
681
+173
+34% +$68.9K 0.02% 189
2024
Q1
$203K Buy
+508
New +$192K 0.01% 231

Other funds holding ISRG

Klingman & Associates's ISRG Position: Q2 2026 in Review

Klingman & Associates increased its Intuitive Surgical (ISRG) stake by 38% in Q2 2026, buying an estimated $200K and bringing the position to 1,665 shares worth $662K. The position accounts for 0.03% of the portfolio, ranked #173.

Klingman & Associates first reported a position in ISRG in Q1 2024 and has held it in 10 quarters since. The position peaked at $692K in Q4 2025. 2,250 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

  • Klingman & Associates held 1,665 shares of Intuitive Surgical worth $662K as of Q2 2026.
  • Klingman & Associates bought 457 Intuitive Surgical shares in Q2 2026, an estimated $200K.
  • Intuitive Surgical made up 0.03% of Klingman & Associates's portfolio in Q2 2026, its #173 holding.
  • Klingman & Associates first reported a position in Intuitive Surgical in Q1 2024 and has held it in 10 quarters since.
  • Klingman & Associates's Intuitive Surgical position peaked at $692K in Q4 2025.
  • 2,250 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Klingman & Associates's 13F filing for Q2 2026, filed 29 Jul 2026.